Glenview Trust’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.96M Buy
430,124
+36,897
+9% +$770K 0.12% 124
2026
Q1
$8.23M Buy
393,227
+90,800
+30% +$1.92M 0.13% 126
2025
Q4
$6.4M Buy
302,427
+59,151
+24% +$1.25M 0.1% 140
2025
Q3
$5.16M Buy
243,276
+44,140
+22% +$930K 0.08% 152
2025
Q2
$4.19M Buy
199,136
+32,000
+19% +$661K 0.07% 166
2025
Q1
$3.47M Buy
167,136
+17,372
+12% +$356K 0.07% 167
2024
Q4
$3.05M Buy
+149,764
New +$3.1M 0.06% 174

Other funds holding IBDW

Glenview Trust's IBDW Position: Q2 2026 in Review

Glenview Trust increased its iShares iBonds Dec 2031 Term Corporate ETF (IBDW) stake by 9.4% in Q2 2026, buying an estimated $770K and bringing the position to 430,124 shares worth $8.96M. The position accounts for 0.12% of the portfolio, ranked #124.

Glenview Trust first reported a position in IBDW in Q4 2024 and has held it in 7 quarters since. 290 funds tracked by Wall St. Rank hold IBDW as of Q2 2026.

  • Glenview Trust held 430,124 shares of iShares iBonds Dec 2031 Term Corporate ETF worth $8.96M as of Q2 2026.
  • Glenview Trust bought 36,897 iShares iBonds Dec 2031 Term Corporate ETF shares in Q2 2026, an estimated $770K.
  • iShares iBonds Dec 2031 Term Corporate ETF made up 0.12% of Glenview Trust's portfolio in Q2 2026, its #124 holding.
  • Glenview Trust first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • 290 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q2 2026.

Based on Glenview Trust's 13F filing for Q2 2026, filed 11 Aug 2026.